Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock

Critical Care Medicine

Volumn 35, Issue 6, 2007, Pages 1536-1542

  Sundén Cullberg, Jonas ^a   Nyström, Thomas ^b   Lee, Martin L ^c   Mullins, Gail E ^a   Tokics, Leif ^a   Andersson, Jan ^a   Norrby Teglund, Anna ^a   Treutiger, Carl Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; Hyperglycemia; Inflammation; Resistin; Septic shock; Severe sepsis

Indexed keywords

CREATININE; CYTOKINE; D DIMER; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; LIPOPOLYSACCHARIDE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APACHE; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; PROTEIN SECRETION; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SWEDEN; UNIVERSITY HOSPITAL; UPREGULATION;

EID: 34249287709     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000266536.14736.03     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312
3. Kusminski CM, McTernan PG, Kumar S: Role of resistin in obesity, insulin resistance, and type II diabetes. Clin Sci (Lond) 2005; 109:243-256
4. Patel L, Buckels AC, Kinghorn IJ, et al: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300:472-476
5. Savage DB, Sewter CP, Klenk ES, et al: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50:2199-2202
6. Lehrke M, Reilly MP, Millington SC, et al: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1:e45
7. Silswal N, Singh AK, Aruna B, et al: Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem Biophys Res Commun 2005; 334:1092-1101
8. Lu SC, Shieh WY, Chen CY, et al: Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530:158-162
9. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982
10. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
11. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Chest 1992; 101:1644-1655
12. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33:564-573
13. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
14. Vincent JL, Moreno R, Takala J, et al: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
15. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251
16. Axelsson J, Bergsten A, Qureshi AR, et al: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69:596-604
17. Verma S, Li SH, Wang CH, et al: Resistin promotes endothelial cell activation: Further evidence of adipokine-endothelial interaction. Circulation 2003; 108:736-740
18. Bokarewa M, Nagaev I, Dahlberg L, et al: Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174:5789-5795
19. Tilg H, Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation, and immunity. Nat Rev Immunol 2006; 6:772-783
20. McTernan PG, Kusminski CM, Kumar S: Resistin. Curr Opin Lipidol 2006; 17:170-175